科研成果详情

题名Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway
作者
发表日期2023-03-09
发表期刊Frontiers in pharmacology   影响因子和分区
语种英语
原始文献类型Journal Article ; Article
关键词LPS Nrf2 acute lung injury ferroptosis urolithin a
其他关键词RESPIRATORY-DISTRESS-SYNDROME ; PREVENTION ; APOPTOSIS
摘要Acute lung injury (ALI) is a life-threatening disease with high incidence and mortality rates. Urolithin A (UA) is a pomegranate intestinal flora metabolite with anti-inflammatory, antioxidant, and anti-aging properties. Ferroptosis is a critical factor in lipopolysaccharide (LPS)-induced acute lung injury (ALI). However, the link between UA and ferroptosis is unknown. The purpose of this research was to look into the role of UA in regulating LPS-induced ferroptosis in ALI. The current study used LPS to injure two models, one BEAS-2B cell injury model and one ALI mouse model. UA effectively alleviated LPS-induced ALI compared to the LPS group by lowering in vivo lung wet/dry weight ratio, reactive oxygen species, and malondialdehyde production, as well as superoxide dismutase, catalase, and glutathione depletion. Furthermore, by increasing GPX4 and SLC7A11 expression and decreasing Fe2+ levels, lung histopathological damage, inflammatory cytokine secretion, and ferroptosis levels can be significantly reduced. The Keap1-Nrf2/HO-1 pathway was upregulated by UA, which inhibited LPS-induced ALI and ferroptosis. ML385 inhibited UA's protective effect against LPS-induced ALI. These findings suggested that UA could be a novel potential therapeutic target for ALI
资助项目General Program (Key Program, Major Research Plan) of the National Natural Science Foundation of China [81470225]; Basic Science Foundation of Wenzhou City [Y2020003]
出版者FRONTIERS MEDIA SA
ISSN1663-9812
EISSN1663-9812
卷号14
DOI10.3389/fphar.2023.1067402
页数14
WOS类目Pharmacology & Pharmacy
WOS研究方向Pharmacology & Pharmacy
WOS记录号WOS:000957600800001
收录类别PUBMED ; SCIE ; SCOPUS
URL查看原文
PubMed ID36969874
SCOPUSEID2-s2.0-85150623704
通讯作者地址[Cai, Chang]Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou,China
Scopus学科分类Pharmacology;Pharmacology (medical)
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/174160
专题第一临床医学院(信息与工程学院)、附属第一医院
药学院(分析测试中心)
附属第一医院
仁济学院
通讯作者Cai, Chang
作者单位
1.Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou,China;
2.School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou,China;
3.Renji College of Wenzhou Medical University,Wenzhou,China
第一作者单位第一临床医学院(信息与工程学院)、附属第一医院;  附属第一医院
通讯作者单位第一临床医学院(信息与工程学院)、附属第一医院;  附属第一医院
第一作者的第一单位第一临床医学院(信息与工程学院)、附属第一医院;  附属第一医院
推荐引用方式
GB/T 7714
Lou, Lejing,Wang, Min,He, Jingjing,et al. Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway[J]. Frontiers in pharmacology,2023,14.
APA Lou, Lejing., Wang, Min., He, Jingjing., Yang, Song., Meng, Fanxi., ... & Cai, Chang. (2023). Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway. Frontiers in pharmacology, 14.
MLA Lou, Lejing,et al."Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway".Frontiers in pharmacology 14(2023).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Lou, Lejing]的文章
[Wang, Min]的文章
[He, Jingjing]的文章
百度学术
百度学术中相似的文章
[Lou, Lejing]的文章
[Wang, Min]的文章
[He, Jingjing]的文章
必应学术
必应学术中相似的文章
[Lou, Lejing]的文章
[Wang, Min]的文章
[He, Jingjing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。